Latest Advances

  • Condition: Acquired Hemophilia A (AHA)
  • Journal: Medicine
  • Treatment Used: Rituximab and rFVIIa
  • Number of Patients: 1
  • Published —
This article reviewed the case of a patient with acquired hemophilia A (bleeding disorder that interferes with the body's blood clotting process; AHA) treated with rituximab and rFVIIA.
  • Condition: Bullous Pemphigoid (BP) Induced by Ustekinumab
  • Journal: European journal of hospital pharmacy : science and practice
  • Treatment Used: Corticosteroids, Dapsone, and Ustekinumab Discontinuation
  • Number of Patients: 1
  • Published —
This case report describes a 75-year-old woman diagnosed with bullous pemphigoid (skin lesions; BP) induced by ustekinumab treated with corticosteroids, dapsone, and ustekinumab discontinuation.
  • Condition: Psychiatric Comorbidity in Individuals with Bullous Pemphigoid (BP)
  • Journal: BMC psychiatry
  • Treatment Used: Prescribed Medications
  • Number of Patients: 6470450
  • Published —
This study investigated the association between bullous pemphigoid (skin disorder; BP) and all bullous disorders (ABD) with a broad array of psychiatric disorders, exploring the influence of prescribed medications.
  • Condition: Benign Mucous Membrane Pemphigoid
  • Journal: The Journal of dermatological treatment
  • Treatment Used: Rituximab
  • Number of Patients: 24
  • Published —
This study tested the safety and efficacy of using rituximab to treat patients with benign mucous membrane pemphigoid.
  • Condition: Bullous Pemphigoid (BP) in COVID-19 Pandemic Era
  • Journal: Dermatologic therapy
  • Treatment Used: Immunosuppressive Therapy
  • Number of Patients: 0
  • Published —
This article discusses the management of bullous pemphigoid (BP), an autoimmune skin blistering disease, during the COVID-19 pandemic.
  • Condition: Acquired Hemophilia A (AHA) Complicated by Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid (BP)
  • Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
  • Treatment Used: Prednisolone, Immunosuppressive Therapy, Cyclophosphamide, and Rituximab (RTX)
  • Number of Patients: 1
  • Published —
This case report describes a 72-year-old man who developed dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid (skin disorder; BP) and acquired hemophilia A (AHA) treated with prednisolone, immunosuppressive therapy, cyclophosphamide, and rituximab (RTX).
  • Condition: Drug-Induced Bullous Pemphigoid with Multiple Sclerosis
  • Journal: Multiple sclerosis and related disorders
  • Treatment Used: Teriflunomide
  • Number of Patients: 1
  • Published —
This case report describes a patient that used teriflunomide for multiple sclerosis and experienced drug-induced bullous pemphigoid as a result.
  • Condition: Bullous Pemphigoid
  • Journal: Journal of the American Academy of Dermatology
  • Treatment Used: Dupilumab
  • Number of Patients: 13
  • Published —
In this study, researchers evaluated the safety and effectiveness of dupilumab for the treatment of bullous pemphigoid.
  • Condition: Bullous Pemphigoid with Type 2 Diabetes
  • Journal: Diabetes & metabolic syndrome
  • Treatment Used: Dipeptidyl Peptidase 4 Inhibitors
  • Number of Patients: 30000
  • Published —
This study investigated the incidence of bullous pemphigoid in patients taking dipeptidyl peptidase 4 inhibitors for their type 2 diabetes.
  • Condition: Elderly Patient with Bullous Pemphigoid (BP) with Intractable Pruritus
  • Journal: Dermatology online journal
  • Treatment Used: Dupilumab
  • Number of Patients: 1
  • Published —
This article described the case of an elderly patient with bullous pemphigoid (rare skin condition that causes large, fluid-filled blisters; BP) with intractable pruritus (unpleasant sensation that provokes the desire to scratch) who was treated with dupilumab.
  • Condition: Cutaneous Autoimmune Bullous Diseases
  • Journal: Dermatologic therapy
  • Treatment Used: Dupilumab
  • Number of Patients: 0
  • Published —
This article discusses the potential treatment of cutaneous autoimmune bullous (blistering skin) diseases with dupilumab.
  • Condition: Pemphigus Vulgaris with Psoriasis Vulgaris
  • Journal: Dermatologic therapy
  • Treatment Used: Methotrexate and Low-Dose Methylprednisolone
  • Number of Patients: 1
  • Published —
The study researched the outcomes of a case of pemphigus vulgaris with psoriasis vulgaris.
Showing 1-12 of 24